NLM Digital Collections

Search

Start Over Formats Text ✖Remove constraint Formats: Text Subjects United States ✖Remove constraint Subjects: United States Languages English ✖Remove constraint Languages: English Genre Technical Report ✖Remove constraint Genre: Technical Report Recently Added Within 3 Months ✖Remove constraint Recently Added: Within 3 Months

41. COVID-19 mortality rates across noncore, micropolitan, and metropolitan counties by community characteristics, December 2020-January 2021

Author(s):
Zahnd, Whitney E., author
Gadag, Khyathi, author
Ullrich, Fred, author
Mueller, Keith J., 1951- author
Publication:
Iowa City, IA : Rural Policy Research Institute, January 2023
Subject(s):
COVID-19 -- mortality
Local Government
Rural Population -- statistics & numerical data
Socioeconomic Factors
State Government
Urban Population -- statistics & numerical data
United States

42. COVID-19: USAID plans to share lessons learned from efforts to meet global vaccination goal : report to congressional addressees

Publication:
Washington, DC : United States Government Accountability Office, September 2023
Subject(s):
COVID-19 Vaccines -- supply & distribution
Global Health
Government Regulation
Immunization Programs
International Cooperation
Legislation, Medical
United States
United States. Agency for International Development

44. Certain Medicare beneficiaries, such as urban and Hispanic beneficiaries, were more likely than others to use telehealth during the first year of the COVID-19 pandemic

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2022
Subject(s):
COVID-19
Government Regulation
Hispanic or Latino
Medicare
Telemedicine -- statistics & numerical data
Urban Population
United States

47. Changes in the list prices of prescription drugs, 2017-2023

Author(s):
Bosworth, Arielle, author
Sheingold, Steven, author
Finegold, Kenneth, author
Sayed, Bisma A., author
De Lew, Nancy, author
Sommers, Benjamin D., author
Publication:
Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, Office of Health Policy, October 6, 2023
Subject(s):
Drug Costs -- trends
Prescription Drugs -- economics
United States

49. Community care hubs: a promising model for health and social care coordination

Author(s):
Breslau, Joshua, author
Rasmussen, Petra W., author
Qureshi, Nabeel Shariq, author
Peet, Evan D., author
Publication:
[Washington, D.C.] : Office of the Assistant Secretary for Planning and Evaluation, Administration for Community Living, U.S. Deparment of Health and Human Serivcies, November 2023
Subject(s):
Community Health Services -- organization & administration
Social Determinants of Health
Social Support
United States

50. Competition in prescription drug markets, 2017-2022

Author(s):
Parasrampuria, Sonal, author
Murphy, Stephen J. (Stephen James), author
Publication:
Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation (ASPE), U.S. Department of Health and Human Services, December 2023
Subject(s):
Drug Costs -- statistics & numerical data
Drug Costs -- trends
Economic Competition
Drug Industry -- economics
Drug Industry -- trends
Prescription Drugs -- economics
United States

51. Complex, time-consuming, and frustrating: searching for in-network diabetes care with marketplace insurance

Author(s):
Silliman, Rebecca, author
McNally, Erin, author
Vargas-Sullivan, Cruz, author
Schleifer, David, author
Publication:
[Brooklyn, New York] : Public Agenda, 2023
Subject(s):
Diabetes Mellitus, Type 2 -- therapy
Health Insurance Exchanges
Health Services Accessibility -- statistics & numerical data
Insurance Coverage -- statistics & numerical data
Socioeconomic Factors
United States

52. Compliance policy regarding blood and blood component donation suitability, donor eligibility and source plasma quarantine hold requirements: guidance for industry

Publication:
Silver Spring, MD : Center for Biologics Evaluation and Research, October 2023
Subject(s):
Blood Banking -- standards
Blood Donation -- standards
Blood Donors
Donor Selection -- standards
Government Regulation
Guideline Adherence
Plasma
United States

55. Considerations for the use of real-world data and real-world evidence to support regulatory decision-making for drug and biological products: guidance for industry

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, August 2023
Subject(s):
Biological Products
Clinical Trials as Topic
Data Analysis
Decision Making
Drug Approval
Drug Industry
Drug and Narcotic Control
Government Regulation
United States
United States.

56. The consistently low percentage of Medicare enrollees receiving medication to treat their opioid use disorder remains a concern

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, December 2023
Subject(s):
Government Regulation
Medicare
Opiate Overdose -- prevention & control
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
United States

59. Defense health care: DOD assessment needed to ensure TRICARE behavioral health coverage goals are being met : report to congressional committees

Publication:
Washington, DC : United States Government Accountability Office, December 2023
Subject(s):
Behavioral Medicine
Government Programs
Government Regulation
Legislation, Medical
Mental Health Services
Military Family
Military Health Services
United States
United States. Department of Defense